BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Inagaki K, Kunisho S, Takigawa H, Yuge R, Oka S, Tanaka S, Shimamoto F, Chayama K, Kitadai Y. Role of tumor-associated macrophages at the invasive front in human colorectal cancer progression. Cancer Sci 2021;112:2692-704. [PMID: 33964093 DOI: 10.1111/cas.14940] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Maradonna F, Fontana CM, Sella F, Giommi C, Facchinello N, Rampazzo C, Caichiolo M, Hoseinifar SH, Dalla Valle L, Van Doan H, Carnevali O. A zebrafish HCT116 xenograft model to predict anandamide outcomes on colorectal cancer. Cell Death Dis 2022;13:1069. [PMID: 36564370 DOI: 10.1038/s41419-022-05523-z] [Reference Citation Analysis]
2 Przygodzka P, Soboska K, Sochacka E, Pacholczyk M, Braun M, Kassassir H, Papiewska-Pająk I, Kielbik M, Boncela J. Neuromedin U secreted by colorectal cancer cells promotes a tumour-supporting microenvironment. Cell Commun Signal 2022;20:193. [PMID: 36482448 DOI: 10.1186/s12964-022-01003-1] [Reference Citation Analysis]
3 Akter R, Kim K, Kwon HY, Kim Y, Eom YW, Cho HM, Cho MY. EMR1/ADGRE1 Expression in Cancer Cells Upregulated by Tumor-Associated Macrophages Is Related to Poor Prognosis in Colorectal Cancer. Biomedicines 2022;10. [PMID: 36551877 DOI: 10.3390/biomedicines10123121] [Reference Citation Analysis]
4 Jing F, Liu X, Chen X, Wu F, Gao Q. Tailoring biomaterials and applications targeting tumor-associated macrophages in cancers. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1049164] [Reference Citation Analysis]
5 He Y, Han Y, Fan AH, Li D, Wang B, Ji K, Wang X, Zhao X, Lu Y. Multi-perspective comparison of the immune microenvironment of primary colorectal cancer and liver metastases. J Transl Med 2022;20:454. [PMID: 36195882 DOI: 10.1186/s12967-022-03667-2] [Reference Citation Analysis]
6 Zheng SM, Chen H, Sha WH, Chen XF, Yin JB, Zhu XB, Zheng ZW, Ma J. Oxidized low-density lipoprotein stimulates CD206 positive macrophages upregulating CD44 and CD133 expression in colorectal cancer with high-fat diet. World J Gastroenterol 2022; 28(34): 4993-5006 [PMID: 36160648 DOI: 10.3748/wjg.v28.i34.4993] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ma J, Chen XQ, Xiang ZL. Identification of a Prognostic Transcriptome Signature for Hepatocellular Carcinoma with Lymph Node Metastasis. Oxid Med Cell Longev 2022;2022:7291406. [PMID: 35847584 DOI: 10.1155/2022/7291406] [Reference Citation Analysis]
8 Manzoor S, Muhammad JS, Maghazachi AA, Hamid Q. Autophagy: A Versatile Player in the Progression of Colorectal Cancer and Drug Resistance. Front Oncol 2022;12:924290. [DOI: 10.3389/fonc.2022.924290] [Reference Citation Analysis]
9 Zhu L, Huang Y, Li H, Shao S. Helicobacter pylori promotes gastric cancer progression through the tumor microenvironment. Appl Microbiol Biotechnol 2022. [PMID: 35723694 DOI: 10.1007/s00253-022-12011-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Ryu HS, Lee JL, Kim CW, Yoon YS, Park IJ, Lim S, Yu CS, Kim JH, Kim JC. Correlative significance of tumor regression grade and ypT category in patients undergoing preoperative chemoradiotherapy for locally advanced rectal cancer. Clinical Colorectal Cancer 2022. [DOI: 10.1016/j.clcc.2022.02.001] [Reference Citation Analysis]
11 Ålgars A, Kemppinen L, Fair-Mäkelä R, Mustonen H, Haglund C, Jalkanen S. Stage I-IV Colorectal Cancer Prognosis Can Be Predicted by Type and Number of Intratumoral Macrophages and CLEVER-1+ Vessel Density. Cancers (Basel) 2021;13:5988. [PMID: 34885098 DOI: 10.3390/cancers13235988] [Reference Citation Analysis]
12 Shin HC, Seo I, Jeong H, Byun SJ, Kim S, Bae SU, Kwon SY, Lee HW. Prognostic Impact of Tumor-Associated Macrophages on Long-Term Oncologic Outcomes in Colorectal Cancer. Life (Basel) 2021;11:1240. [PMID: 34833118 DOI: 10.3390/life11111240] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Han L, Wang S, Wei C, Fang Y, Huang S, Yin T, Xiong B, Yang C. Tumour microenvironment: a non-negligible driver for epithelial-mesenchymal transition in colorectal cancer. Expert Rev Mol Med 2021;23:e16. [PMID: 34758892 DOI: 10.1017/erm.2021.13] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
14 Callejas BE, Blyth GAD, Jendzjowsky N, Wang A, Babbar A, Koro K, Wilson RJA, Kelly MM, Cobo ER, McKay DM. Interleukin-4 Programmed Macrophages Suppress Colitis and Do Not Enhance Infectious-Colitis, Inflammation-Associated Colon Cancer or Airway Hypersensitivity. Front Immunol 2021;12:744738. [PMID: 34691050 DOI: 10.3389/fimmu.2021.744738] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
15 Galbraith NJ, Wood C, Steele CW. Targeting Metastatic Colorectal Cancer with Immune Oncological Therapies. Cancers (Basel) 2021;13:3566. [PMID: 34298779 DOI: 10.3390/cancers13143566] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
16 Inagaki K, Kunisho S, Takigawa H, Yuge R, Oka S, Tanaka S, Shimamoto F, Chayama K, Kitadai Y. Role of tumor-associated macrophages at the invasive front in human colorectal cancer progression. Cancer Sci 2021;112:2692-704. [PMID: 33964093 DOI: 10.1111/cas.14940] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]